Translational Genomics and Epigenomics Laboratory

Site

Translational Genomics and Epigenomics Laboratory – MED

Accreditation No.

19912

Site No.

23962

Date of Accreditation

21 Dec 2017

Address

Level 7, Harold Stokes Building, Austin Hospital, 145 Studley Road
Heidelberg, VIC 3084
Australia

mdhs.unimelb.edu.au/centre-for-cancer-research

Contact

Prof Alexander Dobrovic P: +61 (03) 94965778

Availability

Services available to external clients

Supervision

Not Applicable

Scope of Accreditation

ISO 15189 (2012)

Human Pathology

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood Blood borne tumours; Breast cancer; Solid tumours
Molecular genetics - Bioinformatic analysis DNA sequences; RNA sequences Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Tertiary analysis - Data annotation and interpretation
Molecular genetics - DNA extraction Blood; Body fluids; Buffy coat; Formalin fixed paraffin embedded tissue sections; Plasma; Tissues Viable DNA; Viable DNA for sequencing
Molecular genetics - DNA sequencing Blood; Extracted DNA; Formalin fixed paraffin embedded tissue sections; Tissues DNA sequence analysis
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA) /cell free DNA (cfDNA)  in cancer screening Blood; Plasma Nucleic acid analysis for specific variants
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes Blood; Fluids; Formalin fixed paraffin embedded tissue sections; Plasma; Tissues Blood borne tumours; Essential thrombocythemia (ET); Glioblastoma; Inherited cancer syndromes; MGMT promoter methylation analysis; MLH1 promoter methylation analysis; Nucleic acid analysis for known variants; Nucleic acid analysis for specific variants; Polycythaemia vera; Primary myelofibrosis; Solid tumours
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood; Extracted DNA; Formalin fixed paraffin embedded tissue sections; Leucocytes (leukocytes); Tissues Blood borne tumours; Inherited blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for specific variants; Nucleic acid analysis for unknown variants; Polycythaemia; Solid tumours
Molecular genetics - Predictive genetic testing - Targeted genes Blood; Formalin fixed paraffin embedded tissue sections; Tissues Blood borne tumours; Breast cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited colorectal cancer; Inherited disorders; Inherited solid tumours; Solid tumours
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood; Extracted DNA; Tissues Blood borne tumours; Breast cancer; Hereditary colorectal cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited colorectal cancer; Inherited solid tumours; Solid tumours
Molecular genetics - RNA extraction Blood; Buffy coat; Formalin fixed paraffin embedded tissue sections; Tissues Viable RNA; Viable RNA for sequencing
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes Blood; Formalin fixed paraffin embedded tissue sections; Fresh tissue Blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for unknown variants; Solid tumours
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood; Extracted DNA; Formalin fixed paraffin embedded tissue sections; Plasma; Tissues Blood borne tumours; Breast cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited solid tumours; Solid tumours

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.